Aderajew Waka

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Tobias Alexander, Ramona Sarfert, Jens Klotsche et al. · Annals of the Rheumatic Diseases · 2015 · 363 citations · Full text

Life Sciences, Immunology, Pharmacology +15

Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors

Tobias Alexander, Qingyu Cheng, Jens Klotsche et al. · European Journal of Immunology · 2018 · 71 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The intracellular 52‐kd Ro/SSA autoantigen in keratinocytes is up‐regulated by tumor necrosis factor α via tumor necrosis factor receptor I

Velia Gerl, Björn Hostmann, Christa Johnen et al. · Arthritis & Rheumatism · 2005 · 37 citations

Life Sciences, Dermatology, Immunology +14

Multi-center evaluation of autoantibodies to the major ribosomal P C22 epitope

Michael Mähler, Nancy Agmon‐Levin, M. van Liempt et al. · Rheumatology International · 2010 · 22 citations

Life Sciences, Immunology, Molecular Biology +13